Loss of calbindin-D28K from aging human cholinergic basal forebrain: Relation to neuronal loss

Journal of Comparative Neurology

Volumn 455, Issue 2, 2003, Pages 249-259

  Geula, Changiz ^a,b   Bu, Jing ^a,b   Nagykery, Nicholas ^a,b   Scinto, Leonard F M ^b,c   Chan, Jennifer ^b   Joseph, Jeffrey ^a,b   Parker, Robert ^a,b   Wu, Chuang Kuo ^d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Calcium binding proteins; Choline acetyltransferase; Nerve growth factor receptor; Normal aging

Indexed keywords

CALBINDIN; CALCIUM; CHOLINE ACETYLTRANSFERASE; PROTEIN P75;

ADULT; AGE; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN DEGENERATION; CALCIUM CELL LEVEL; CELL COUNT; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FOREBRAIN; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NEUROCHEMISTRY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; CHOLINERGIC NERVE; COMPARATIVE STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CHOLINERGIC FIBERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSENCEPHALON;

EID: 0037420952     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.10475     Document Type: Article

References (73)

1. Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Schmeidler J, Kanof P, Davis KL. 1995. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits. J Neurochem 64:749-750.
2. Bowen DM, Benton JS, Spillane JA, Smith CCT, Allen SJ. 1982. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 57:191-202.
3. Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, Sims NR, Smith CT, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK, Davison AN. 1983. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem 41:266-272.
4. Clapham DE. 1995. Calcium signaling. Cell 80:259-268.
5. Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. 1999. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 281:1401-1406.
6. de Lacalle S, Iraizoz I, Ma Gonzalo L. 1991. Differential changes in cell size and number in topographic subdivisions of human basal nucleus in normal aging. Neuroscience 43:445-456.
7. DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RAE, Chui HC, Knopman DS, Reeder TM, Shetter AG, Senter HJ, Markesbery WR. 1992. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlates. Ann Neurol 32:625-632.
8. DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett D, Cochran EJ, Kordower JH, Mufson EJ. 2002. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (in press).
9. 28K-containing neurons, and not HSP70-expressing neurons, are more resistant to HIV-1 envelope (gp120) toxicity in cortical cell cultures. J Neurosci Res 42:252-258.
10. D'Orlando C, Fellay B, Schwaller B, Salicio V, Bloc A, Gotzos V, Celio MR. 2001. Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells. Brain Res 909:145-158.
11. Doucette RB, Ball NJ. 1987. Left-right symmetry of neuronal cell counts in the nucleus basalis of Meynert of control and of Alzheimer-diseased brains. Brain Res 422:357-360.
12. Figueredo-Cardenas G, Harris CL, Anderson KD, Reiner A. 1998. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types. Exp Neurol 149:356-372.
13. Fine A, Hoyle C, Maclean CJ, Levatte TL, Baker HF, Ridley RM. 1997. Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys. Neuroscience 81:331-343.
14. 45Ca autoradiographic study. Brain Res 624:94-102.
15. Gahwiler BH, Rietschin L, Knopfel T, Enz A. 1990. Continuous presence of nerve growth factor is required for maintenance of cholinergic septal neurons in organotypic slice cultures. Neuroscience 36:27-31.
16. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB. 1989. Midbrain dopaminergic cell loss in Parkinson's disease: Computer visualization. Ann Neurol 26:507-514.
17. German DC, Manaye KF, Sonsalla PK, Brooks BA. 1992. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: Sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci 648:42-62.
18. Geula C, Mesulam M-M. 1989. Cortical cholinergic fibers in aging and Alzheimer's disease: A morphometric study. Neuroscience 33:469-481.
19. Geula C, Mesulam M-M. 1996. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb Cortex 6:165-177.
20. Geula C, Mesulam M-M. 1999. Cholinergic systems in Alzheimer disease. In: Terry RD, Katzman R, Bick KL, Sisodia SS, editors. Alzheimer Disease. Philadelphia: Lippincott Williams and Wilkins. p 269-292.
21. Geula C, Schatz CR, Mesulam MM. 1993. Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience 54:461-476.
22. Geula C, Mesulam M-M, Saroff DM, Wu C-K. 1998. Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer's disease. J Neuropathol Exp Neurol 57:63-75.
23. Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI. 1999. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 411:693-704.
24. 2+ permeability of KA-AMPA-gated glutamate channels depends on subunit composition. Science 252:851-853.
25. Hugon J, Hugon F, Esclaire F, Lesort M, Diop AG. 1996. The presence of calbindin in rat cortical neurons protects in vitro from oxydative stress. Brain Res 707:288-292.
26. Iacopino AM, Christakos S. 1990. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 87:4078-4082.
27. 28K-containing neurons in animal models of neurodegeneration: Possible protection from excitotoxicity. Brain Res Mol Brain Res 13:251-261.
28. 28K-containing neurons in animal models of neurodegeneration: Possible protection from excitotoxicity. Brain Res Mol Brain Res 13:251-261.
29. 28K: A potential neuroprotective protein. Neurodegeneration 3:1-20.
30. Ikonomovic MD, Armstrong DM. 1996. Distribution of AMPA receptor subunits in the nucleus basalis of Meynert in aged humans: Implications for selective neuronal degeneration. Brain Res 716:229-232.
31. Ikonomovic MD, Nocera R, Mizukami K, Armstrong DM. 2000. Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert. Exp Neurol 166:363-375.
32. Khachaturian Z. 1985. Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105.
33. Leanza G, Muir J, Nilsson OG, Wiley RG, Dunnett SB, Bjorklund A. 1996. Selective immunolesioning of the basal forebrain cholinergic system disrupts short-term memory in rats. Eur J Neurosci 8:1535-1544.
34. Lehericy S, Hirsch EC, Cervera-Pierot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw J-J, Javoy-Agid F, Agid Y. 1993. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol 330:15-31.
35. Levey AI, Bolam JP, Rye DB, Hallanger AE, Demuth RM, Mesulam M-M, Wainer BH. 1986. A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride. J Histochem Cytochem 34:1449-1457.
36. Mann DMA, Yates PO, Marcyniuk B. 1984. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to accumulation of lipofuscin pigment. Mech Ageing Dev 25:189-204.
37. Martin LJ, Blackstone CD, Levey AI, Huganir RL, Price DL. 1993. Cellular localizations of AMPA glutamate receptors within the basal forebrain magnocellular complex of rat and monkey. J Neurosci 13:2249-2263.
38. Mattson MP, Rychlik B, Chu C, Christakos S. 1991. Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D 28K in cultured hippocampal neurons. Neuron 6:41-51.
39. Mattson MP, Cheng B, Davis D, Bryant K, Lieberberg I, Rydel RE. 1992. β-Amyloid peptides destabilize celcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
40. 2+ homeostasis in Alzheimer's disease. TINS 16:409-414.
41. Mattson MP, Rydel RE, Lieberburg I, Smith-Swintosky VL. 1993b. Altered calcium signaling and neuronal injury: Stroke and Alzheimer's disease as examples. Ann N Y Acad Sci 679:1-21.
42. Mesulam M-M, Geula C. 1988. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 275:216-240.
43. 2+ homeostasis. Progr Neurobiol 37:255-285.
44. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L. 2001. Mild congnitive impairment represents early-stage Alzheimer's disease. Arch Neurol 58:397-405.
45. Mufson EJ, Bothwell M, Kordower JH. 1989. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain. Exp Neurol 105:221-232.
46. Mufson EJ, Presley LN, Kordower JH. 1991. Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: Reduced cell numbers and colocalization with cholinergic neurons. Brain Res 539:19-30.
47. Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH. 2000. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 427:19-30.
48. Mufson EJ, Ma SY, Dills J, Cochran EJ, Leugrans S, Wuu J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH. 2002. Loss of basal forebrain p75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 443:136-153.
49. Muir JL, Dunnett SB, Robbins TW, Everitt BJ. 1992. Attentional functions of the forebrain cholinergic systems: Effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 89:611-622.
50. Nagykery N, Wu C-K, Geula C. 2001. Calretinin immunoreactivity is present in the primate basal forebrain cholinergic neurons. Soc Neurosci Abstr 599.14.
51. Orrenius S, Nicotera P. 1994. The calcium ion and cell death. J Neural Transm Suppl, p 1-11.
52. 2+)-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol Lett 357:64-65.
53. Page KJ, Everitt BJ. 1995. The distribution of neurons coexpressing immunoreactivity to AMPA-sensitive glutamate receptor subtypes (GluR1-4) and nerve growth factor receptor in the rat basal forebrain. Eur J Neurosci 7:1022-1033.
54. Perry EK, Blessed G, Tomlinson BE, Perry TH, Crow TJ, Cross AJ, Dockray GJ, Dimaline R, Arragui A. 1981. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol Aging 2:251-256.
55. 28K gene transfer via herpes simplex virus amplicon vector decreases hippocampal damage in vivo following neurotoxic insults. J Neurochem 73:1200-1205.
56. 28k in HEK 293 cells. Cell Calcium 29:277-287.
57. Rogers JD, Brogan D, Mirra SS. 1985. The nucleus basalis of Meynert in neurological disease: A quantitative morphological study. Ann Neurol 17:163-170.
58. Scharfman HE, Schwartzkroin PA. 1989a. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science 246:257-260.
59. Scharfman HE, Schwartzkroin PA. 1989b. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science 246:249-262.
60. Scinto LFM, Frosch M, Wu C-K, Daffner KR, Gedi N, Geula C. 2001. Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients. Neurobiol Aging 22:729-736.
61. Selden N, Geula C, Hersh L, Mesulam M-M. 1994. Human striatum: Chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Neuroscience 60:621-636.
62. Trump BF, Berezesky IK. 1995. Calcium-mediated cell injury and cell death. FASEB J 9:219-228.
63. Tuszynski MH, U HS, Amaral DG, Gage FH. 1990. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 10:3604-3614.
64. 2+ signals in developing rat dorsal root ganglion neurons studied in excised tissue. Brain Res 635:231-237.
65. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL. 1994. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14:167-186.
66. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. 1982. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215:1237-1239.
67. Whitehouse PJ, Hedreen JC, White CL, Price DL. 1983. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13:243-348.
68. 28K from basal forebrain cholinergic neurons in the marmoset. Soc Neurosci Abstr 22:203.
69. Wu C-K, Mesulam M-M, Geula C. 1997. Age-related loss of calbindin from human basal forebrain cholinergic neurons. Neuroreport 8:2209-2213.
70. Wu C-K, Kuznetsov D, Armstrong DM, Geula C. 1999. Age-related loss of calbindin from human basal forebrain cholinergic neurons: Relation to other pathology. Soc Neurosci Abstr 25:1802.
71. Wu C-K, Hersh LB, Geula C. 2000a. Cyto- and chemoarchitecture of basal forebrain cholinergic neurons in the common marmoset (Callithirx jacchus). Exp Neurol 165:306-326.
72. Wu C-K, Nagykery N, Geula C. 2000b. Age-realted loss of calcium binding proteins may predispose basal forebrain cholinergic neurons to degeneration in Alzheimer's disease. Neurobiol Aging 21:S121.
73. 28K. Brain Res 526:303-307.